Skip to main content
 

Bodyport

Bodyport

Bodyport™ is a biomarker-guided digital therapeutics company addressing complex chronic conditions by delivering actionable insights gleaned from unique health signals and simple, at-home experiences. The company is tackling heart failure first with its Bodyport for Heart Health solution, to noninvasively assess heart function and fluid status at home via our Cardiac Scale, providing patients and their care teams comprehensive insights to tailor therapeutic actions and personalized insights — keeping people living with heart failure healthier and out of the hospital.

More News

  • Smartphone apps, wearable trackers helped people with heart disease boost physical activity

  • Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

  • AccurKardia receives patent for AI-ECG cardiac amyloidosis detection